20.05.2026, 20:55

Kazakhstan's PollenVax vaccine for wormwood allergy could reach market by 2030-2032

ASTANA. May 20 (Interfax-Kazakhstan) - Kazakh scientists are developing what they say is the world's first recombinant allergy vaccine, PollenVax, against wormwood pollen, with the vaccine potentially reaching the market by 2030-2032, the National Agriculture Scientific and Educational Center said.

To read the full news articles, Subscribe.

05:38PM
EU to help Armenia diversify export markets - ambassador

05:29PM
Kazakhstan sends $76 million gasoline smuggling case to court

05:15PM
Tokayev discusses Kazakhstan's Gaza stabilization initiatives with Peace Board envoy

05:08PM
Russia, Vietnam discuss creating strategic oil reserve in country, LNG supplies - Russian deputy PM

04:03PM
Apple removed Russia's Max app from store without explanation - minister

04:00PM
Kazakhstan central bank expected to hold rate at 18% or cut to 17.5%

03:46PM
AVERAGE WEIGHTED RATE ON JUNE 4, 2026 IS 485.34 TENGE FOR $1

03:44PM
Interfax and Yandex will join forces to develop digital business solutions

03:21PM
More preferences needed for oil sector as reserves become harder to recover, impacting budget revenue - Siluanov

03:15PM
ADNOC subsidiary mulling new investment opportunities with SOCAR in Azerbaijan, internationally

03:12PM
Russian-U.S. dialogue ongoing, more active steps possible soon - Russian presidential envoy